Search Results

Filter
  • 1-10 of  83,700,097 results for "%22United States%22"
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

The Next Chapter of Renal Denervation After US Food and Drug Administration Approval.

  • Authors : Vongpatanasin W; Hypertension Section (W.V.), Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.; Cardiology Division (W.V., T.A.)., Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.

Subjects: United States Food and Drug Administration*; United States ; Humans

  • Source: Circulation [Circulation] 2024 Mar 05; Vol. 149 (10), pp. 760-763. Date of Electronic Publication: 2024 Mar 04.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763

Record details

×
Academic Journal

Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study.

  • Authors : Muñoz MA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. .; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA. .

Subjects: United States Food and Drug Administration*; Female ; Humans

  • Source: Drug safety [Drug Saf] 2024 Apr; Vol. 47 (4), pp. 377-387. Date of Electronic Publication: 2024 Feb 14.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Commentary on the Revision of SAMHSA's National Outcome Measures (NOMs) for Discretionary Programs.

  • Authors : Riske-Morris M; Begun Center for Violence Prevention Research and Education, Jack, Joseph and Morton Mandel School of Applied Social Sciences, Case Western Reserve University, 11402, Bellflower Road, Cleveland, OH, 44106-7167, USA.; Hussey DL

Subjects: United States Substance Abuse and Mental Health Services Administration* ; Substance-Related Disorders*/Substance-Related Disorders*/Substance-Related Disorders*/therapy; United States

  • Source: The journal of behavioral health services & research [J Behav Health Serv Res] 2024 Apr; Vol. 51 (2), pp. 302-308. Date of Electronic Publication: 2023 Nov 03.Publisher: Springer Country of Publication: United States NLM ID: 9803531 Publication Model:

Record details

×
Periodical

'Damning' FDA inspection report undermines Alzheimer's drug.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Scientific Misconduct* ; Spiro Compounds*/Spiro Compounds*/Spiro Compounds*/therapeutic use

  • Source: Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. 1165-1166. Date of Electronic Publication: 2024 Mar 14.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID:

Record details

×
Academic Journal

High-Performing Teamlets in Primary Care: A Qualitative Comparative Analysis.

  • Authors : Chen MA; From the Division of Health Policy & Economics, Department of Population Health Sciences, Weill Cornell Medical College (MAC, EMO, LPC), Division of General Internal Medicine, Department of Medicine, University of California, San Diego (MAC), Department of Social Sciences, University of Houston - Downtown (CR), Comparative Health Outcomes, Policy and Economics Institute, Department of Pharmacy, University of Washington (JL), Department of Family Community Medicine, University of California, San Francisco (TB). .; Rubinson C

Subjects: Primary Health Care* ; United States Department of Veterans Affairs*; United States

  • Source: Journal of the American Board of Family Medicine : JABFM [J Am Board Fam Med] 2024 Mar 11; Vol. 37 (1), pp. 105-111. Date of Electronic Publication: 2024 Mar 11.Publisher: American Board of Family Medicine Country of Publication: United States NLM ID: 101256526

Record details

×
Academic Journal

The FDA's proposed rule on laboratory-developed tests: what happens next?

  • Authors : Genzen JR; Department of Pathology, University of Utah Health, Salt Lake City, UT, US.; ARUP Laboratories, Salt Lake City, UT, US.

Subjects: United States Food and Drug Administration*; Humans ; United States

  • Source: Laboratory medicine [Lab Med] 2024 Mar 07; Vol. 55 (2), pp. 109-110.Publisher: Oxford University Press Country of Publication: England NLM ID: 0250641 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Addressing the Challenge of Common Chronic Diseases - A View from the FDA.

Subjects: Chronic Disease*/Chronic Disease*/Chronic Disease*/therapy ; United States Food and Drug Administration*; Humans

  • Source: The New England journal of medicine [N Engl J Med] 2024 Feb 08; Vol. 390 (6), pp. 490-492. Date of Electronic Publication: 2024 Feb 03.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562

Record details

×
Academic Journal

A Physician Attack on the FDA - Will the Supreme Court Reduce Access to Mifepristone?

  • Authors : Watson K; From the Feinberg School of Medicine, Northwestern University, Chicago.

Subjects: Abortion, Induced*/Abortion, Induced*/Abortion, Induced*/legislation & jurisprudence ; Abortion, Induced*/Abortion, Induced*/Abortion, Induced*/methods ; Mifepristone*/Mifepristone*/Mifepristone*/supply & distribution

  • Source: The New England journal of medicine [N Engl J Med] 2024 Feb 08; Vol. 390 (6), pp. 563-567. Date of Electronic Publication: 2024 Jan 24.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562

Record details

×
Periodical

EPA scraps plan to end all testing in mammals by 2035.

Subjects: United States Environmental Protection Agency* ; Animal Experimentation* ; Toxicity Tests*

  • Source: Science (New York, N.Y.) [Science] 2024 Jan 19; Vol. 383 (6680), pp. 248. Date of Electronic Publication: 2024 Jan 18.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID:

Record details

×
Academic Journal

Point: The Need for Additional FDA Regulations in Laboratory Medicine.

  • Authors : Konnick EQ; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.

Subjects: United States Food and Drug Administration* ; Clinical Laboratory Techniques*/Clinical Laboratory Techniques*/Clinical Laboratory Techniques*/standards ; Government Regulation*

  • Source: The journal of applied laboratory medicine [J Appl Lab Med] 2024 Jan 03; Vol. 9 (1), pp. 151-154.Publisher: Oxford University Press Country of Publication: England NLM ID: 101693884 Publication Model: Print Cited Medium: Print ISSN: 2576-9456

Record details

×
  • 1-10 of  83,700,097 results for "%22United States%22"